ATC Group: C01BD05 Ibutilide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01BD05 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01B Antiarrhythmics, class I and III
4 C01BD Antiarrhythmics, class III
5 C01BD05 Ibutilide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 1 mg

Active ingredients in C01BD05

Active Ingredient Description
Ibutilide

Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).

Medicines in this ATC group

United States (US)

Austria (AT)

Canada (CA)

Finland (FI)

Netherlands (NL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.